MULN, PHUN and DWACW are among pre market gainers
franckreporter/iStock via Getty Images
- Pliant Therapeutics (PLRX) +46% as mid-stage trial for lung disease therapy meets key goals.
- Digital World Acquisition (DWACW) +32%.
- Nyxoah (NYXH) +22% FDA nod to start trial for sleeping disorder.
- Phunware (PHUN) +20%.
- Digital World Acquisition (DWAC) +13% as analysts says Musk terminating deal is a nightmare scenario.
- TDH Holdings (PETZ) +8%.
- American Rebel Holdings (AREB) +7%.
- Mullen Automotive (MULN) +6%.